As Philadelphia enters weeks of 90-degree days, the city is faced with two crises at once: heat exposure and the coronavirus.
NextHealth PHL covers the healthcare industry in Philadelphia and the work of scientists, doctors, and healthcare companies in Cellicon Valley. NextHealth PHL puts a special emphasis on healthcare news in the vibrant cell and gene therapies sector.
Researchers from the University of Pennsylvania launched the first-ever clinical trial to genetically edit the immune cells of cancer patients using the technology.
Nabriva has developed a new antibiotic to treat community-acquired bacterial pneumonia and is pioneering new treatments for other infectious diseases.
Direct Primary Care is an affordable payment model for healthcare services that could help improve health outcomes in underserved communities.
A new study from Penn Medicine found that liquid biopsies may be effective in tracking disease progression in patients with glioblastoma.
For nearly 20 years, Integral Molecular has been developing disease-fighting antibodies and fueling the discovery of new treatments for incurable illnesses.
At its Navy Yard facility, Adaptimmune is working to develop the next generation of T-cell treatments for solid tumor cancers.
A new nationwide study led by Penn Medicine aims to identify the cause of common transplant surgery complications to improve transplant survival rates.
From new investment models for biotech to ice cream as medicine, the new citywide innovation fest explored what’s next for the city’s science sector.
Philly’s Beyond/Hello dispensary is on a mission to destigmatize medical marijuana in Pennsylvania.
The Caspar Wistar Fellows program will help aspiring scientists pursue new research in cancer biology, immunology, virology and genetics.
With the combined expertise of leading gene and cell therapy researchers, Tmunity is developing the next wave of immunotherapies for cancer and other diseases.
A new documentary by former Philadelphia news anchor Renee Chenault-Fattah takes a closer look at what can be done to reverse the trend.
The first-of-its-kind study wants to determine whether CBD can relieve symptoms of arthritis in dogs.
UE LifeSciences developed the iBreastExam, a handheld, battery-operated device, that provides easy access to breast cancer screening.
In light of the recent news, Penn oncologist Susan Domcheck debunks a few myths about men and breast cancer.